Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
iScience ; 25(4): 104069, 2022 Apr 15.
Article in English | MEDLINE | ID: mdl-35372812

ABSTRACT

FBXO41 is a neuron-specific E3 ligase subunit implicated in epileptic encephalopathies. Fbxo41 null mutant (KO) mice show behavioral deficits and early lethality. Here, we report that loss of FBXO41 causes defects in synaptic transmission and brain development. Cultured Fbxo41 KO neurons had normal morphology and showed no signs of degeneration. Single-cell electrophysiology showed a lower synaptic vesicle release probability in excitatory neurons. Inhibitory neurons exhibited reduced synaptophysin expression, a smaller readily releasable pool, and decreased charge transfer during repetitive stimulation. In Fbxo41 KO hippocampal slices at postnatal day 6, the dentate gyrus was smaller with fewer radial-glial-like cells and immature neurons. In addition, neuronal migration was delayed. Two-photon calcium imaging showed a delayed increase in network activity and synchronicity. Together, our findings point toward a role for FBXO41 in synaptic transmission and postnatal brain development, before behavioral deficits are detected in Fbxo41 KO mice.

2.
Dev Neurobiol ; 81(2): 207-225, 2021 03.
Article in English | MEDLINE | ID: mdl-33453138

ABSTRACT

Spontaneous Synchronous Network Activity (SSA) is a hallmark of neurodevelopment found in numerous central nervous system structures, including neocortex. SSA occurs during restricted developmental time-windows, commonly referred to as critical periods in sensory neocortex. Although part of the neocortex, the critical period for SSA in the medial prefrontal cortex (mPFC) and the underlying mechanisms for generation and propagation are unknown. Using Ca2+ imaging and whole-cell patch-clamp in an acute mPFC slice mouse model, the development of spontaneous activity and SSA was investigated at cellular and network levels during the two first postnatal weeks. The data revealed that developing mPFC neuronal networks are spontaneously active and exhibit SSA in the first two postnatal weeks, with peak synchronous activity at postnatal days (P)8-9. Networks remain active but are desynchronized by the end of this 2-week period. SSA was driven by excitatory ionotropic glutamatergic transmission with a small contribution of excitatory GABAergic transmission at early time points. The neurohormone oxytocin desynchronized SSA in the first postnatal week only without affecting concurrent spontaneous activity. By the end of the second postnatal week, inhibiting GABAA receptors restored SSA. These findings point to the emergence of GABAA receptor-mediated inhibition as a major factor in the termination of SSA in mouse mPFC.


Subject(s)
Neurons , Prefrontal Cortex , Animals , Mice , Neurons/physiology , Neurotransmitter Agents , Oxytocin , Receptors, GABA-A
3.
Dev Neurobiol ; 76(4): 357-74, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26097169

ABSTRACT

Developing networks in the immature nervous system and in cellular cultures are characterized by waves of synchronous activity in restricted clusters of cells. Synchronized activity in immature networks is proposed to regulate many different developmental processes, from neuron growth and cell migration, to the refinement of synapses, topographic maps, and the mature composition of ion channels. These emergent activity patterns are not present in all cells simultaneously within the network and more immature "silent" cells, potentially correlated with the presence of silent synapses, are prominent in different networks during early developmental periods. Many current network analyses for detection of synchronous cellular activity utilize activity-based pixel correlations to identify cellular-based regions of interest (ROIs) and coincident cell activity. However, using activity-based correlations, these methods first underestimate or ignore the inactive silent cells within the developing network and second, are difficult to apply within cell-dense regions commonly found in developing brain networks. In addition, previous methods may ignore ROIs within a network that shows transient activity patterns comprising both inactive and active periods. We developed analysis software to semi-automatically detect cells within developing neuronal networks that were imaged using calcium-sensitive reporter dyes. Using an iterative threshold, modulation of activity was tracked within individual cells across the network. The distribution pattern of both inactive and active, including synchronous cells, could be determined based on distance measures to neighboring cells and according to different anatomical layers.


Subject(s)
Imaging, Three-Dimensional/methods , Membrane Potentials/physiology , Neurons/physiology , Pattern Recognition, Automated/methods , Software , Voltage-Sensitive Dye Imaging/methods , Animals , Calcium/metabolism , Cells, Cultured , Embryonic Stem Cells/physiology , Entorhinal Cortex/drug effects , Entorhinal Cortex/growth & development , Entorhinal Cortex/physiology , GABA-A Receptor Antagonists/pharmacology , Humans , Membrane Potentials/drug effects , Mice, Inbred C57BL , Neural Pathways/drug effects , Neural Pathways/growth & development , Neural Pathways/physiology , Neurons/drug effects , Periodicity , Pyridazines/pharmacology , Tissue Culture Techniques
4.
Eur J Neurosci ; 41(7): 878-88, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25704806

ABSTRACT

Adenosine is a neuromodulator mostly acting through A1 (inhibitory) and A2A (excitatory) receptors in the brain. A2B receptors (A(2B)R) are G(s/q)--protein-coupled receptors with low expression in the brain. As A(2B)R function is largely unknown, we have now explored their role in the mouse hippocampus. We performed electrophysiological extracellular recordings in mouse hippocampal slices, and immunological analysis of nerve terminals and glutamate release in hippocampal slices and synaptosomes. Additionally, A(2B)R-knockout (A(2B)R-KO) and C57/BL6 mice were submitted to a behavioural test battery (open field, elevated plus-maze, Y-maze). The A(2B)R agonist BAY60-6583 (300 nM) decreased the paired-pulse stimulation ratio, an effect prevented by the A(2B)R antagonist MRS 1754 (200 nM) and abrogated in A(2B)R-KO mice. Accordingly, A(2B)R immunoreactivity was present in 73 ± 5% of glutamatergic nerve terminals, i.e. those immunopositive for vesicular glutamate transporters. Furthermore, BAY 60-6583 attenuated the A(1)R control of synaptic transmission, both the A(1)R inhibition caused by 2-chloroadenosine (0.1-1 µM) and the disinhibition caused by the A(1)R antagonist DPCPX (100 nM), both effects prevented by MRS 1754 and abrogated in A(2B)R-KO mice. BAY 60-6583 decreased glutamate release in slices and also attenuated the A(1)R inhibition (CPA 100 nM). A(2B)R-KO mice displayed a modified exploratory behaviour with an increased time in the central areas of the open field, elevated plus-maze and the Y-maze and no alteration of locomotion, anxiety or working memory. We conclude that A(2B)R are present in hippocampal glutamatergic terminals where they counteract the predominant A(1)R-mediated inhibition of synaptic transmission, impacting on exploratory behaviour.


Subject(s)
Hippocampus/physiology , Receptor, Adenosine A1/metabolism , Receptor, Adenosine A2B/metabolism , Synaptic Transmission/physiology , 2-Chloroadenosine/pharmacology , Acetamides/pharmacology , Adenosine A1 Receptor Agonists/pharmacology , Adenosine A1 Receptor Antagonists/pharmacology , Adenosine A2 Receptor Agonists/pharmacology , Adenosine A2 Receptor Antagonists/pharmacology , Aminopyridines/pharmacology , Animals , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Glutamic Acid/metabolism , Hippocampus/drug effects , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice, Inbred C57BL , Mice, Knockout , Purines/pharmacology , Receptor, Adenosine A2B/genetics , Synaptic Transmission/drug effects , Vesicular Glutamate Transport Proteins/metabolism , Xanthines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...